The association between lipid profiles and breast cancer among Taiwanese women

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 9, 2007, Pages 1219-1223

  Chang, Shun Jen ^a   Hou, Ming Feng ^a   Tsai, Shih Meng ^a   Wu, Szu Hsien ^b,c   Ann Hou, Linda ^d   Ma, Hsu ^c   Shann, Tzyy Yuan ^b   Wu, Szu Hua ^e   Tsai, Li Yu ^e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apolipoprotein; Breast cancer; Lipid profiles; Very low density lipoprotein cholesterol

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; INFORMED CONSENT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TAIWAN;

ADULT; APOLIPOPROTEIN A-I; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHOLESTEROL, VLDL; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; ODDS RATIO; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TAIWAN;

EID: 34548577115     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.263     Document Type: Article

References (27)

1. Department of Health. Cancer registry annual report 2005. Taipei: Department of Health, Executive Yuan, 2006.
2. Cheng SH, Tsou MH, Liu MC, Jian JJ, Cheng JC, Leu SY, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 2000;63:213-23.
3. Boyd NF, McGuire V. Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst 1990;82:460-8.
4. Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Larson DB, et al. Serum cholesterol and cancer in the NHANES I epidemiologic follow up study. National Health and Nutrition Examination Survey. Lancet 1987;2:298-301.
5. Han C, Zhang H-T, Du L, Liu X, Jing J, Zhao X, et al. Serum levels of leptin, insulin, and lipids in relation to breast cancer in China. Endocrine 2005;26:19-24.
6. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004;96:1152-60.
7. Gaard M, Tretli S, Urdal P. Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control 1994;5:501-9.
8. Kumar K, Sachdanandam P, Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem Int 1991;23:581-9.
9. Kokoglu E, Karaarslan I, Karaarslan HM, Baloglu H. Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett 1994;82:175-8.
10. Gerber M, Richardson S, Crastes de Paulet P, Pujol H, Crastes de Paulet A. Relationship between vitamin E and polyunsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer 1989;64:2347-53.
11. Feldman EB, Carter AC. Circulating lipids and lipoproteins in women with metastatic breast carcinoma. J Clin Endocrinol Metab 1971;33:8-13.
12. Mastroianni A, Bellati C, Facchetti G, Oldani S, Franzini C, Berrino F. Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy. Clin Biochem 2000;33:513-6.
13. Elisaf MS, Bairaktari ET, Nicolaides C, Kakaidi B, Tzallas CS, Katsaraki A, et al. Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. Eur J Cancer 2001;37:1510-3.
14. Wynder EL. Dietary factors related to breast cancer. Cancer 1980;46:899-904.
15. Kesteloot H, Huang DX, Yang XS, Claes J, Rosseneu M, Geboers J, et al. Serum lipids in the People's Republic of China. Comparison of western and eastern populations. Arteriosclerosis 1985;5:427-33.
16. Punnonen R, Jokela H, Kudo R, Punnonen K, Pyykko K, Pystynen P. Serum lipids in Finnish and Japanese postmenopausal women. Atherosclerosis 1987;68:241-7.
17. Halfon ST, Rifkind BM, Harlap S, Kaufmann NA, Baras M, Slater PE, et al. Plasma lipids and lipoproteins in adult Jews of different origins: the Jerusalem Lipid Research Clinic Prevalence Study. Isr J Med Sci 1982;18:1113-20.
18. Vatten LJ, Foss OP. Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 1990;50:2341-6.
19. May FE, Westley BR. Estrogen regulated messenger RNAs in human breast cancer cells. Biomed Pharmacother 1995;49:400-14.
20. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. Br Med J 2000;321:624-8.
21. Tikkanen MJ, Nikkila EA, Kuusi T, Sipinen SU. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J Clin Endocrinol Metab 1982;54:1113-7.
22. Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, et al. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 2005;14:33-40.
23. Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, et al. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. J Clin Endocrinol Metab 1981;53:1123-32.
24. Kamath SK, Murillo G, Chatterton RT Jr, Hussain EA, Amin D, Mortillaro E, et al. Breast cancer risk factors in two distinct ethnic groups: Indian and Pakistani vs. American premenopausal women. Nutr Cancer 1999;35:16-26.
25. Mooradian AD, Haas MJ, Wong NC. The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev 2006;27:2-16.
26. Chie WC, Li CY, Huang CS, Chang KJ, Lin RS. Body size as a factor in different ages and breast cancer risk in Taiwan. Anticancer Res 1998;18:565-70.
27. Pathak DR, Whittemore AS. Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol 1992;135:153-68.